Skip to Primary Navigation

Chemours says CEO, CFO, and controller violated ethics code

A medical researcher holds a pipette in a medical laboratory.
Photo: Matthew Horwood/Getty Images

Three top executives engaged in financial practices that triggered an anonymous report to the Chemours ethics hotline, the company revealed.

Global chemical business Chemours has announced that, after an internal probe, three of its top executives – CEO Mark Newman, CFO Jonathan Lock, and Controller and Principal Accounting Officer Camela Wisel – engaged in unethical financial practices.

An internal review of an anonymous report made to the Chemours ethics hotline

Get full access, free for a month

Start your 28-day free trial to continue reading and access
all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience